Australia markets open in 9 hours 18 minutes

Cartesian Therapeutics, Inc. (RNAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.97-0.65 (-3.69%)
At close: 04:00PM EDT
16.80 -0.17 (-1.00%)
After hours: 07:35PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6766
Avg. Estimate-1.19-1.01-8.02-4.18
Low estimate-2.27-2.4-17.31-10.9
High estimate-0.55-0.28-5.1-0.77
Year ago EPS-2.1-1.8-49.8-8.02
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6766
Avg. Estimate1.83M2.54M11.22M12.29M
Low estimateN/AN/A5.8MN/A
High estimate6M6.75M23.84M49.75M
Year ago sales5.25M6.55M26M11.22M
Sales growth (year/est)-65.10%-61.20%-56.90%9.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.4-1.75-1.05-0.88
Actual EPS-2.1-1.8-41.7-10.5
Difference0.3-0.05-40.65-9.62
Surprise %12.50%-2.90%-3,871.40%-1,093.20%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.19-1.01-8.02-4.18
7 days ago-0.76-1.19-8.68-4.83
30 days ago-1.19-1.15-8.22-5.07
60 days ago-0.9-0.9-3.21-2.95
90 days ago-1.5-1.5-3.9-1.5
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A322
Up last 30 daysN/A322
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2N/AN/A1
Growth estimatesRNACIndustrySector(s)S&P 500
Current qtr.43.30%N/AN/AN/A
Next qtr.43.90%N/AN/AN/A
Current year83.90%N/AN/AN/A
Next year47.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A